These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 35968380)

  • 21. Management of insomnia.
    Kirkwood CK
    J Am Pharm Assoc (Wash); 1999; 39(5):688-96; quiz 713-4. PubMed ID: 10533351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.
    Dündar Y; Dodd S; Strobl J; Boland A; Dickson R; Walley T
    Hum Psychopharmacol; 2004 Jul; 19(5):305-22. PubMed ID: 15252823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eszopiclone: its use in the treatment of insomnia.
    Monti JM; Pandi-Perumal SR
    Neuropsychiatr Dis Treat; 2007 Aug; 3(4):441-53. PubMed ID: 19300573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern.
    Parrino L; Boselli M; Spaggiari MC; Smerieri A; Terzano MG
    Clin Neuropharmacol; 1997 Jun; 20(3):253-63. PubMed ID: 9197949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What every dentist should know about the "z-sedatives".
    McKenzie WS; Rosenberg M
    J Mass Dent Soc; 2007; 56(3):44-5. PubMed ID: 18069595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical and forensic toxicology of Z-drugs.
    Gunja N
    J Med Toxicol; 2013 Jun; 9(2):155-62. PubMed ID: 23404347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The newer sedative-hypnotics].
    Sukys-Claudino L; Moraes WA; Tufik S; Poyares D
    Braz J Psychiatry; 2010 Sep; 32(3):288-93. PubMed ID: 20945020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
    Terzano MG; Rossi M; Palomba V; Smerieri A; Parrino L
    Drug Saf; 2003; 26(4):261-82. PubMed ID: 12608888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
    Sateia MJ; Buysse DJ; Krystal AD; Neubauer DN; Heald JL
    J Clin Sleep Med; 2017 Feb; 13(2):307-349. PubMed ID: 27998379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA
    Berro LF; Andersen ML; Tufik S; Howell LL
    Neuropharmacology; 2017 Sep; 123():299-309. PubMed ID: 28495376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics.
    Nutt DJ; Stahl SM
    J Psychopharmacol; 2010 Nov; 24(11):1601-12. PubMed ID: 19942638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eszopiclone stimulates the hypothalamo-pituitary-adrenal axis in the rat.
    Pechnick RN; Lacayo LM; Manalo CM; Bholat Y; Spivak I
    Eur J Pharmacol; 2011 Jul; 661(1-3):22-6. PubMed ID: 21540024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse.
    Cardinali DP; Golombek DA; Rosenstein RE; Brusco LI; Vigo DE
    Pharmacol Res; 2016 Jul; 109():12-23. PubMed ID: 26438969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
    Griebel G; Perrault G; Sanger DJ
    J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of insomnia. Pharmacological approaches and their limitations].
    Costentin J
    Bull Acad Natl Med; 2011 Oct; 195(7):1583-94; discussion 1594-5. PubMed ID: 22812162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
    Sanna E; Busonero F; Talani G; Carta M; Massa F; Peis M; Maciocco E; Biggio G
    Eur J Pharmacol; 2002 Sep; 451(2):103-10. PubMed ID: 12231378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of eszopiclone in the treatment of insomnia.
    Morin AK; Willett K
    Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.